CLINICAL STUDY
High-dose intravenous isosorbide-dinitrate is safer and better than Bi-PAP ventilation combined with conventional treatment for severe pulmonary edema
Ahuva Sharon, MDa,
Isaac Shpirer, MDb,
Edo Kaluski, MD, FACC ,
Yaron Moshkovitz, MD ,
Olga Milovanov, MDa ,
Roman Polak, MDa,
Alex Blatt, MD ,
Avi Simovitz, EMS||,
Ori Shaham, EMS||,
Zvi Faigenberg, MD||,
Michael Metzger ,
David Stav, MDb,
Robert Yogev, MDa,
Ahuva Golik, MDa ,
Rikardo Krakover, MD ,
Zvi Vered, MD, FACC and
Gad Cotter, MD
a Department of Medicine, Assaf-Harofeh Medical Center, Zerifin, Israel
b Department of Pulmonology, Assaf-Harofeh Medical Center, Zerifin, Israel
The Cardiology Institute, Assaf-Harofeh Medical Center, Zerifin, Israel
Clinical Pharmacology Research Unit, Assaf-Harofeh Medical Center, Zerifin, Israel
|| Magen-David-Adom (EMS Service), Zefirin, Israel
Manuscript received December 3, 1999;
revised manuscript received March 15, 2000,
accepted April 26, 2000.
Reprint requests and correspondence: Gad Cotter MD, The Cardiology Institute, Assaf-Harofeh Medical Center, 70300, Zerifin Israel cotterg{at}hotmail.com
OBJECTIVE
To determine the feasibility, safety and efficacy of bilevel positive airway ventilation (BiPAP) in the treatment of severe pulmonary edema compared to high dose nitrate therapy.
BACKGROUND
Although noninvasive ventilation is increasingly used in the treatment of pulmonary edema, its efficacy has not been compared prospectively with newer treatment modalities.
METHODS
We enrolled 40 consecutive patients with severe pulmonary edema (oxygen saturation <90% on room air prior to treatment). All patients received oxygen at a rate of 10 liter/min, intravenous (IV) furosemide 80 mg and IV morphine 3 mg. Thereafter patients were randomly allocated to receive 1) repeated boluses of IV isosorbide-dinitrate (ISDN) 4 mg every 4 min (n = 20), and 2) BiPAP ventilation and standard dose nitrate therapy (n = 20). Treatment was administered until oxygen saturation increased above 96% or systolic blood pressure decreased to below 110 mm Hg or by more than 30%. Patients whose conditions deteriorated despite therapy were intubated and mechanically ventilated. All treatment was delivered by mobile intensive care units prior to hospital arrival.
RESULTS
Patients treated by BiPAP had significantly more adverse events. Two BiPAP treated patients died versus zero in the high dose ISDN group. Sixteen BiPAP treated patients (80%) required intubation and mechanical ventilation compared to four (20%) in the high dose ISDN group (p = 0.0004). Myocardial infarction (MI) occurred in 11 (55%) and 2 (10%) patients, respectively (p = 0.006). The combined primary end point (death, mechanical ventilation or MI) was observed in 17 (85%) versus 5 (25%) patients, respectively (p = 0.0003). After 1 h of treatment, oxygen saturation increased to 96 ± 4% in the high dose ISDN group as compared to 89 ± 7% in the BiPAP group (p = 0.017). Due to the significant deterioration observed in patients enrolled in the BiPAP arm, the study was prematurely terminated by the safety committee.
CONCLUSIONS
High dose ISDN is safer and better than BiPAP ventilation combined with conventional therapy in patients with severe pulmonary edema.
|
Abbreviations and Acronyms
| | ANOVA | = analysis of variance | | BiPAP | = bilevel positive pressure ventilation | | CK | = creatine phosphokinase | | CPAP | = continuous positive airway pressure | | EPAP | = expiratory positive airway pressure | | IPAP | = inspiratory positive airway pressure | | ISDN | = isosorbide dinitrate | | LVEDP | = left ventricular end diastolic pressure | | MI | = myocardial infarction |
|
This article has been cited by other articles:

|
 |

|
 |
 
BET 1. MANAGING ACUTE PULMONARY OEDEMA: HIGH OR STANDARD DOSE GLYCERYL TRINITRATE?
Emerg. Med. J.,
May 1, 2009;
26(5):
357 - 358.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Plaisance, R. Pirracchio, C. Berton, E. Vicaut, and D. Payen
A randomized study of out-of-hospital continuous positive airway pressure for acute cardiogenic pulmonary oedema: physiological and clinical effects
Eur. Heart J.,
December 1, 2007;
28(23):
2895 - 2901.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Ferrari, F. Olliveri, G. De Filippi, A. Milan, F. Apra, A. Boccuzzi, M. Converso, and P. Navalesi
Noninvasive Positive Airway Pressure and Risk of Myocardial Infarction in Acute Cardiogenic Pulmonary Edema: Continuous Positive Airway Pressure vs Noninvasive Positive Pressure Ventilation
Chest,
December 1, 2007;
132(6):
1804 - 1809.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Penuelas MD, F. Frutos-Vivar MD, and A. Esteban MD PhD
Noninvasive positive-pressure ventilation in acute respiratory failure
Can. Med. Assoc. J.,
November 6, 2007;
177(10):
1211 - 1218.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Milo-Cotter, K. F. Adams, C. M. O'Connor, N. Uriel, E. Kaluski, G. M. Felker, B. Weatherley, Z. Vered, and G. Cotter
Acute heart failure associated with high admission blood pressure -- A distinct vascular disorder?
Eur J Heart Fail,
February 1, 2007;
9(2):
178 - 183.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Masip, M. Roque, B. Sanchez, R. Fernandez, M. Subirana, and J. A. Exposito
Noninvasive Ventilation in Acute Cardiogenic Pulmonary Edema: Systematic Review and Meta-analysis
JAMA,
December 28, 2005;
294(24):
3124 - 3130.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R Agarwal, A N Aggarwal, D Gupta, and S K Jindal
Non-invasive ventilation in acute cardiogenic pulmonary oedema
Postgrad. Med. J.,
October 1, 2005;
81(960):
637 - 643.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. W. Elliott
Non-invasive ventilation for acute respiratory disease
Br. Med. Bull.,
March 31, 2005;
72(1):
83 - 97.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Endorsed by the European Society of Intensive Care, Authors/Task Force Members, M. S. Nieminen, M. Bohm, M. R. Cowie, H. Drexler, G. S. Filippatos, G. Jondeau, Y. Hasin, J. Lopez-Sendon, et al.
Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: The Task Force on Acute Heart Failure of the European Society of Cardiology
Eur. Heart J.,
February 2, 2005;
26(4):
384 - 416.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Masip, J. Paez, A. J. Betbese, F. Vecilla, and S. Nava
Noninvasive Ventilation for Pulmonary Edema in the Emergency Room
Am. J. Respir. Crit. Care Med.,
May 1, 2004;
169(9):
1072 - 1073.
[Full Text]
|
 |
|

|
 |

|
 |
 
S D Crane, M W Elliott, P Gilligan, K Richards, and A J Gray
Randomised controlled comparison of continuous positive airways pressure, bilevel non-invasive ventilation, and standard treatment in emergency department patients with acute cardiogenic pulmonary oedema
Emerg. Med. J.,
March 1, 2004;
21(2):
155 - 161.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. D. Bersten
Noninvasive Ventilation for Cardiogenic Pulmonary Edema: Froth and Bubbles?
Am. J. Respir. Crit. Care Med.,
December 15, 2003;
168(12):
1406 - 1408.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Nava, G. Carbone, N. DiBattista, A. Bellone, P. Baiardi, R. Cosentini, M. Marenco, F. Giostra, G. Borasi, and P. Groff
Noninvasive Ventilation in Cardiogenic Pulmonary Edema: A Multicenter Randomized Trial
Am. J. Respir. Crit. Care Med.,
December 15, 2003;
168(12):
1432 - 1437.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Brochard
Mechanical ventilation: invasive versus noninvasive
Eur. Respir. J.,
November 16, 2003;
22(47_suppl):
31s - 37s.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Liesching, H. Kwok, and N. S. Hill
Acute Applications of Noninvasive Positive Pressure Ventilation
Chest,
August 1, 2003;
124(2):
699 - 713.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Cotter, Y. Moshkovitz, E. Kaluski, O. Milo, Y. Nobikov, A. Schneeweiss, R. Krakover, and Z. Vered
The role of cardiac power and systemic vascular resistance in the pathophysiology and diagnosis of patients with acute congestive heart failure
Eur J Heart Fail,
August 1, 2003;
5(4):
443 - 451.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Kaluski, I. Kobrin, R. Zimlichman, A. Marmor, O. Krakov, O. Milo, A. Frey, S. Kaplan, R. Krakover, A. Caspi, et al.
RITZ-5: randomized intravenousTeZosentan (an endothelin-A/B antagonist)for the treatment of pulmonary edema: A prospective, multicenter, double-blind, placebo-controlled study
J. Am. Coll. Cardiol.,
January 15, 2003;
41(2):
204 - 210.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A.L. Clark and M. Greenstone
Un bout de souffle: ventilatory support for pulmonary oedema
Eur. Heart J.,
September 1, 2002;
23(17):
1326 - 1328.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.A. Kelly, D.E. Newby, T.A. Mcdonagh, T.W. Mackay, J. Barr, N.A. Boon, H.J. Dargie, and N.J. Douglas
Randomised controlled trial of continuous positive airway pressure and standard oxygen therapy in acute pulmonary oedema. Effects on plasma brain natriuretic peptide concentrations
Eur. Heart J.,
September 1, 2002;
23(17):
1379 - 1386.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Brochard
Noninvasive Ventilation for Acute Respiratory Failure
JAMA,
August 28, 2002;
288(8):
932 - 935.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Non-invasive ventilation in acute respiratory failure
Thorax,
March 1, 2002;
57(3):
192 - 211.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Jackson and S. Jones
NIPPV for acute cardiogenic pulmonary oedema
Emerg. Med. J.,
November 1, 2001;
18(6):
464 - 465.
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Wysocki and M. Antonelli
Noninvasive mechanical ventilation in acute hypoxaemic respiratory failure
Eur. Respir. J.,
July 1, 2001;
18(1):
209 - 220.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Sacchetti and R. H. Harris
Effectiveness of BiPAP for congestive heart failure
J. Am. Coll. Cardiol.,
May 1, 2001;
37(6):
1754 - 1755.
[Full Text]
[PDF]
|
 |
|
|